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Abstract
Background: To identify the pattern of protein expression in the retina from a patient with
Leber's Congenital Amaurosis (LCA) secondary to a mutation in the AIPL1 gene. The retina from
one eye of a patient with LCA and 7 control eyes were studied. The tissue was subjected to high
resolution two-dimensional gel electrophoresis, image analysis and mass spectrometry, in an effort
to identify differentially regulated proteins.
Results: In the LCA retina seven protein spots were differentially expressed. Six proteins were
significantly up-regulated of which three could be identified as: αA-crystallin, triosephophate
isomerase, and an N-terminal fragment of the β-chain of ATP synthase. One protein spot that was
down-regulated in the LCA retina was identified as a C-terminal fragment of β-tubulin.
Conclusion:  Retinal tissue in LCA is characterised by an up-regulation of αA-crystallin,
triosephosphate isomerase, and ATP synthase (β-chain fragment) and down-regulation of a
fragment of β-tubulin. These proteins/protein fragments may play a crucial role for the retinal
degeneration processes in LCA and other retinal dystrophies.
Background
In 1869 Leber described a disorder associated with con-
genital amaurosis, nystagmus, and the oculodigital sign
that appeared to be a variety of retinitis pigmentosa. This
disorder, now referred to as Leber's congenital amaurosis
(LCA), is a group of autosomal recessive dystrophies with
a heterogenous clinical and genetic background [1]. To
date, mutations of seven genes have been reported to be
implicated in the disease: RetGC1 [2,3], RPE65 [4,5], CRX
[6], AIPL1 [7,8], LRAT [9], CRB1 [10], and RPGRIP [11].
In addition, two other loci may be involved: LCA3 on
14q24 [12] and LCA5 on 6q11-16 [13].
LCA occurs at an incidence of 3/100,000 newborns and
currently no treatment is available. The pathophysiology
of LCA is unknown, however, histological data are con-
sistent with abnormal development of photoreceptor cells
in the retina and extreme premature degeneration of reti-
nal cells [8,14-16]. It is conceivable that analysis of the
differential expression of retinal proteins in LCA may pro-
vide further insight into the pathophysiology of the dis-
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ease. We, therefore, performed proteomic analysis [17] of
retinal tissue in 7 normal persons and one patient with
LCA due to a mutation in the AIPL1 gene [7,8]. APL1 (aryl
hydrocarbon receptor-interacting protein-like 1) is a
member of the FK-506-binding protein family that is spe-
cifically expressed in retinal photoreceptors. The possible
significance of the differential expression of proteins in
the LCA patient as compared to the normal persons is dis-
cussed.
Results
Representative examples of the retinal protein expression
pattern as revealed by 2D-PAGE are shown in figure 1 for
the LCA retina and the normal retina. The overall protein
expression profiles were similar. Fifty seven well-sepa-
rated and clearly focused protein spots were included in
the analysis. Volumes of each of the 57 spots were calcu-
lated. Seven protein spots were found to be differentially
expressed (figure 2) when calculated as described in the
Methods section. Six protein spots from the LCA gel were
significantly up-regulated by a factor of 1.7 – 9.8 (p <
0.05) and one protein spot was significantly down-regu-
lated by a factor of 1.7 (p < 0.05) (Table 1).
Using mass spectrometry 3 of the up-regulated proteins
could be identified as: αA-crystallin, triosephophate iso-
merase, and an N-terminal fragment of ATP synthase.
Three of the up-regulated proteins in the LCA retina could
not be identified. The down-regulated protein was identi-
fied as a C-terminal fragment of β-tubulin. The sequence
coverage of the identified proteins ranged from 11% to
33% (Table 2).
In order to verify the quantitation of spot density on 2D
gels, we also analysed retinal samples by 1D Western blot-
ting using commercially available antibodies. As seen
from the Western blots (figure 3A) it was possible qualita-
tively to verify the molecular weights as well as the differ-
ential expression of each of the four proteins/protein
fragments. β-actin was used as a loading control. In addi-
tion, quantitative densitometry for the immune reactions
(figure 3B) was also carried out. Estimated from the 2D
gels αA-crystallin was up-regulated by a factor 2.39 (table
1) and from the Western blot by a factor 2.74, Triosephos-
phate isomerase by a factor 5.52 (2D gels) and 1.73
(Western blot), ATP synthase β-subunit by a factor 6.88
(2D gels) and 1.40 (Western blot), whereas β-tubulin was
down-regulated by a factor 0.59 (2D gels) versus  0.47
(Western blot). Using these two completely different
methods, data from the 2D gels versus data from Western
blots demonstrated exactly the quantitative trend for each
of the proteins in question.
Scleral tissue was used as a control tissue not known to be
involved in the pathology of LCA, and did not show any
significant difference in protein expression between the
LCA eye and one normal eye (not shown).
Discussion
Leber's congenital amaurosis is an ocular syndrome that
includes retinal dystrophy with lesions characteristic of
retinitis pigmentosa. To date at least seven genes have
been reported to be implicated in the disease, however, it
is unknown how the affected genes as well as other genes
are expressed to develop the dystrophic changes. There-
fore, mapping of the protein expression pattern of the dis-
eased LCA retina may contribute to further understanding
the pathogenesis of the disease.
The aim of this study, was to identify LCA-associated dif-
ferential expression of retinal proteins using 2D-PAGE.
Retinal proteins from one patient and 7 normal individu-
als were compared. Inspected by eye, the overall 2D-PAGE
profile from the LCA patient was similar to that of the nor-
mal individuals. Fifty seven protein spots that were found
to be present in all gels were analysed. In order to estimate
the quantitative similarity of the 2D profiles, the coeffi-
cient of variation was calculated to 24.4% (6.3% to
38.3%) for the normal retinas in this biological material.
Disease-associated differential expression of proteins,
however, was identified in retinal but not scleral tissue
used as a control tissue not known to be involved in the
pathology of LCA. In LCA retina, the expression of 7 pro-
tein spots was altered by at least 1.5-fold when compared
to normal retina. Six protein spots were up-regulated and
one down-regulated in LCA retinal tissue.
Differentially expressed proteins were subsequently
excised from the gels for mass spectrometry identification.
By this process we identified 3 up-regulated proteins as,
αA-crystallin, triosephosphate isomerase, and an N-termi-
nal fragment of ATP synthase. The down-regulated pro-
tein was identified as a C-terminal fragment of β-tubulin.
All these proteins are encoded from nuclear genes except
for ATP synthase which is encoded from the mitochon-
drion genome. Three proteins unfortunately could not be
identified by mass spectrometry. Several reasons may
account for this, e.g. low quantities of protein, peptide
modification due to the silver staining procedure and low
molecular mass proteins generally produce only few pep-
tides for fingerprinting.
αA-crystallin
The α-crystallins belong to the small heat shock protein
family and make up more than 90% of the total dry mass
of the lens [18], and thus contribute to the refractive index
of this structure. The lens αA-crystallin is also expressed in
other eye tissues such as the retinal Müller-cells and the
photoreceptors, and may have similar optical functions inProteome Science 2007, 5:5 http://www.proteomesci.com/content/5/1/5
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Representative 2D gels from LCA retina (A) and from normal retina (B) Figure 1
Representative 2D gels from LCA retina (A) and from normal retina (B). Fifty seven silver-stained spots (encircled) were ana-
lysed. The 6 proteins found to be significantly up-regulated (p < 0.05) are marked by green circles. The single significantly 
down-regulated protein (p < 0.05) is encircled in red. The remaining 50 protein spots included in the analysis are marked by 
blue circles.Proteome Science 2007, 5:5 http://www.proteomesci.com/content/5/1/5
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these cell types. In addition, αA-crystallin possesses a
chaperone-like function and is involved in the first steps
of protein synthesis by binding to the unfolded proteins
to avoid non-specific aggregation. The involvement of αA-
crystallin in human disease has recently been reported by
the observation of a single missense mutation, R116C,
which is associated with cataract formation [19]. The role
of αA-crystallin up-regulation in LCA is unknown, but
could be related to a stressful condition in the retina dur-
ing the disease process.
Triosephosphate isomerase
Triosephosphate isomerase is a glycolytic enzyme catalys-
ing the interconversion of D-glyceraldehyde 3 phosphate
to dihydroxyacetone phosphate (DHAP) in the glycolytic
pathway. Glucose is the major energy source in the brain
and the retina. A strong up-regulation of a glycolytic
enzyme might be associated with an increased glucose
metabolism in the retina of diseased individuals. On the
other hand, if the LCA retina is not particularly metabolic
active the up-regulation could be explained by other as yet
unknown functions of triosephosphate isomerase. As an
example another key glycolytic enzyme, α-enolase, is in
fact a multifunctional protein that possesses additional
extracellular functions besides the well-known intracellu-
lar function [20].
ATP synthase β-subunit (N-terminal fragment)
The ATP synthase is the only protein complex found in the
present study that is encoded by the mitochondrion
genome. The complex consists of a soluble region, F1, and
a membrane bound region, F0. Functionally, the synthase
may be divided into two counter-rotating parts: the rotor
consisting of subunits γ and ε and the cylindrical c subu-
nits while the stator consists of the α3β3 hexamer con-
nected via the δ and b2 subunits to the a subunit. A
detailed review of the structural and functional properties
of the ATP synthase has recently been published [21]. The
a subunit is part of the stator, localized in the membrane
and serves as a channel through which ions may enter and
bind to the rotor. We find that an N-terminal fragment
(the extremity of the protein) of the β subunit is up-regu-
lated in the retina of patients with LCA. This might indi-
cate an increased degradation of the β subunit of ATP
synthase. LCA has previously been associated with muta-
tions at nucleotide 9101 in the ATP synthase of the mito-
chondrion genome [22] as well as with mutation in
another mitochondrial gene, NADH dehydrogenase sub-
unit 4 [23].
β-tubulin, (C-terminal fragment)
β-tubulin (55 kDa) belongs to the tubulin superfamily
that to date consists of seven distinct members, α-, β-, γ-,
δ-, ε-, ζ-, and η-tubulin. The tubulins constitute one of the
major components of the cytoskeleton of eukaryotic cells
and are involved in a variety of processes such as cell divi-
sion, ciliary function and intracellular transport. β-tubulin
forms a heterodimer with α-tubulin that constitutes the
basic building block of microtubules and together with γ-
tubulin appear to be present in all eukaryotic cells, some-
times the only tubulin variety present [24]. The fact that
we find a 20 kDa C-terminal fragment (the extremity of
the protein) of the protein to be down-regulated may
indicate decreased cleavage of β-tubulin, but the signifi-
cance of this finding otherwise remains to be elucidated.
Conclusion
In conclusion, we have by proteomic analysis found sig-
nificant perturbations in the expression of seven retinal
proteins in Leber's congenital amaurosis. There is no
apparent direct functional link between the observed pro-
teins indicating that a complex series of molecular events
are involved in the pathogenesis of the disease. Some of
the differentially regulated proteins could be categorized
as stress regulated proteins and proteins involved in the
formation of energy compounds. It might be that LCA dis-
ease leaves the retina in a "stressful" condition, up-regu-
lating chaperones and with changes in metabolism and
energy consumption.
In this study, it is not possible to negate unequivocally a
contribution of age-related effects on retinal protein
Histograms of adjusted protein spot volumes of the 7 spots  that were found to be differentially regulated Figure 2
Histograms of adjusted protein spot volumes of the 7 spots 
that were found to be differentially regulated. LCA: Actual 
volume. Normal: Mean volume ± SD.
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expression. In a previous study of rat retinal proteins,
however, no age-related effects on proteins displayed by
2D-PAGE were identified [25]. In addition, the tissue spe-
cificity of differential expression of proteins further sup-
ports the contention that the observed differences are
disease and not age related. An analysis of the effects of
ageing on retina protein expression would be required to
resolve this issue.
This study emphasizes that although the identification of
mutations in the human genome is a precondition for
understanding inherited diseases, a full understanding of
the pathophysiology of these diseases requires a detailed
mapping of the structural and metabolic consequences of
the mutations. This may be a laborious and complex chal-
lenge in ocular diseases in general and Leber's congenital
amaurosis in particular.
Methods
Clinical case
The patient was a son of unrelated parents, and his four
years older sister had LCA diagnosed at the age of one
year. At the age of five months he underwent a clinical
examination which showed no light perception in either
of the eyes. Ophthalmoscopy revealed greyish atrophic
retinas, and electroretinography showed extinguished sig-
nals in both eyes. At the age of 22 years the patient was
admitted because of constant headache and pain in both
eyes which he attempted to relieve by poking the eyes. The
clinical examination showed bilateral nystagmus and no
Table 2: Identification of differentially regulated proteins in LCA retina
Protein No. Identification Identified peptides Coverage % pI Mr (kDa) Function Swiss-Prot 
Accession 
Number
15 ND*
23 ND
28 Triosephosphate isomerase IAVAAQNCYK (59–68)
TATPQQAQEVHEK (175–187)
TATPQQAQEVHEKLR (175–189)
SNVSDAVAQSTR (194–205)
IIYGGSVTGATCK (206–218)
20 7.1 26.89 Enzyme P60174
36 αA-crystallin RTLGPFYPSR (12–21)
TLGPFYPSR (13–21)
TVLDSGISEVR (55–65)
QDDHGYISR (104–112)
IQTGLDATHAER (146–157)
AIPVSREEKPTSAPSS (158–173)
33 5.8 20.01 Chaperone P02489
48 β-tubulin (C-terminal fragment) NSSYFVEWIPNNVK (119–132)
TAVCDIPPR (133–141)
RISEQFTAMFR (162–172)
ISEQFTAMFRR (163–173)
11 4.9 26.03 Cytoskeletal P68371
52 ATP synthase β-subunit 
precursor (N-terminal fragment)
LVLEVAQHLGESTVR (95–109)
TIAMDGTEGLVR (110–121)
VLDSGAPIKIPVGPETLGR (125–143)
IMNVIGEPIDER (144–155)
11 5.3 56.54 Oxidative 
phosphorylation
P06576
55 ND
* ND, not determined.
† Spectra obtained by MALDI-TOF were used to search the Swiss-Prot databases. The peptides given were in agreement with measured masses. 
Number in parentheses indicate the position of the peptide in the protein.
Table 1: Comparison of adjusted spot volumes of the 7 protein spots that were found to be differently regulated.
Protein No. Adjusted spot volume (OD × Area) p-value* Relative protein levels in LCA to normal
LCA (n = 1) Normal (n = 7) Mean ± SD
15 1.066 0.616 ± 0.175 0.042 1.73
23 1.505 0.154 ± 0.016 <0.0001 9.78
28 1.600 0.290 ± 0.116 <0.0001 5.52
36 7.345 3.073 ± 0.719 0.001 2.39
48 0.699 1.192 ± 0.173 0.029 0.59
52 2.000 0.291 ± 0.089 <0.0001 6.88
55 1.498 0.423 ± 0.239 0.004 3.54
*The p-value was calculated by comparing the single observation from LCA with the range observed in the normal retina using the t-distribution 
(see Materials and Methods).Proteome Science 2007, 5:5 http://www.proteomesci.com/content/5/1/5
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Western blot analysis of retina from the LCA patient and 3 normal individuals Figure 3
Western blot analysis of retina from the LCA patient and 3 normal individuals. The blots in panel A were incubated with anti-
bodies against the appropriate antigens. β-actin was used as a loading control. The histograms in panel B represent densitome-
try (OD × Area) of the blots. (LCA: Actual volume. Normal: Mean volume ± SD).Proteome Science 2007, 5:5 http://www.proteomesci.com/content/5/1/5
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light perception. Slit lamp examination showed bilateral
keratoconus and posterior polar cataract. Ophthalmos-
copy gave a slightly blurred view of the fundi. The far
periphery was avascular and with hyperpigmentations
dispersed in the retina. On the patient's request both eyes
were enucleated, which relieved the pain immediately.
Control cases
Seven normal individuals 54–81 years old were included.
Five cases were autopsies without known eye diseases. In
the last two cases an orbital exenteration in combination
with enucleation were performed after the persons gradu-
ally developed proptosis and diplopia due to tumors in
the orbit not involving the eyes. In alle cases slit lamb
examination and ophthalmoscopy showed a normal fun-
dus with no inflammation or sheared stress. When com-
pared, no differences were seen in the protein profiles
obtained from the 7 normal individuals.
Tissue processing
Processing of ocular tissue for proteomic analysis in our
laboratory has been approved by the local scientific ethics
committee. Informed consent for the investigations was
obtained from both the LCA patient and the normal indi-
viduals in accordance with the provision of the Declara-
tion of Helsinki. Immediately after enucleation, the eyes
were divided by a section along the horizontal meridian.
In both the LCA patient and the controls a 4 × 4 mm piece
of retina was excised from the section line to represent
equal parts and were prepared for two-dimensional gel
electrophoresis as previously described [27]. From the
LCA patient and from a single control a 4 × 4 mm piece of
sclera was also excised and prepared for two-dimensional
gel electrophoresis.
Two-dimensional Polyacrylamide Gel Electrophoresis (2D-
PAGE)
The first dimension isoelectric focusing (IEF) was per-
formed using non-linear pH 3-10NL IPG strips (Amer-
sham Biosciences). Rehydration of the IPG strip was
performed using the Immobiline DryStrip Reswelling
Tray (Amersham Biosciences). The IPG strip was rehy-
drated for 20 h at room temperature in 400 μl protein
sample containing approximately 100 μg of protein. IEF
was carried out on a Multiphor II electrophoresis unit
(Amersham Biosciences) at 500 V for 0.01 h, 500 V for 3
h, 3500 V for 5 h, and 3500 V for 20 h in a gradient mode
at 17°C using a MultiTemp III Thermostatic Circulator
(Amersham Pharmacia Biotech AB). Prior to the second
dimension SDS-PAGE, the IPG strip was equilibrated for
2 times 15 min under gentle agitation in 10 ml of equili-
bration solution (0.1%, Tris-HCl, pH 6.8, 5.5 M Urea,
0.3% Glycerol, 0.035 M SDS, and 0.065 M DTT). Instead
of DTT, iodoacetamide (14 mM) and traces of bromophe-
nol blue were added to make the second equilibration
solution. For the second dimension the equilibrated IPG
strip was transferred to a home made polyacrylamide gel
(5% stacking and 15% resolving). The electrophoresis for
the second dimension was performed vertically at a max-
imum voltage of 50 V, 5 mA for approximately 20 h in
custom made equipment previously designed and
described [27]. With the employed technique proteins
were separated in the pI range between 3 and 10 (first
dimension) and in the molecular mass range between 10
and 160 kDa (second dimension).
Silver staining
The gels were visualised by silver staining using the proto-
col of Vorum optimised for high sensitivity protein iden-
tification by mass spectrometry [28]. Firstly, the gel was
fixed in 50% (v/v) methanol, 12% (v/v) acetic acid,
0.0185% (v/v) formaldehyde overnight or at least for 1 h,
then washed 3 times for 20 min in 35% (v/v) ethanol and
pre-treated for 1 min in 0.02% (w/v) Na2S2O3, 5H2O,
rinsed in water 2 times for 3 min, stained in 0.2% (w/v)
AgNO3, 0.028% (v/v) formaldehyde for 20 min, rinsed
with water 2 times for 20 s and developed in development
solution: 6% (w/v) Na2CO3, 0.0185% (v/v) formalde-
hyde, 0.0004% (w/v) Na2S2O3, 5H2O, for approximately
3 min. Finally, development was stopped in stop solution:
50% (v/v) methanol, 12% (v/v) acetic acid. The gels were
mounted between two sheets of cellophane and dried.
Analysis of two-dimensional gels
Initially proteins from one normal retina and one LCA ret-
ina were separated by 2D-PAGE. The gels were silver
stained and scanned using a Bio-Rad GS-710 Calibrated
Imaging Densitometer (Bio-Rad Laboratories, Hercules,
CA, USA). The spots were analysed using Bio-Rad Multi-
Analyst (V.1.02) software, which designates a volume
(spot area times density) to each spot, proportional to the
amount of protein. The volume of each spot in the gel was
converted to an adjusted volume normalised to the total
amount of protein in the gel. In an effort to identify differ-
entially expressed proteins, we tested whether the vol-
umes of the protein spots in the LCA gel were different
from the corresponding spots in the normal gel. In this
pilot study 8 proteins were found to be differentially
expressed. We then extended the study by including 6
additional 2D gels from normal retinas, in an effort to
confirm the differential expression of the 8 proteins. After
re-analysis only 7 proteins were found to be significant
differentially expressed.
The difficulty in obtaining adequate samples for analysis
of this very rare human disease makes statistical analysis
complicated, and due to the very limited data set such
analysis should be interpreted with caution. However, we
approached a calculation of the probability that a single
observation (the volume of a given spot in the LCA gel)Proteome Science 2007, 5:5 http://www.proteomesci.com/content/5/1/5
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was within the range of the volumes of the same spot in
the normal gels by using the t-distribution: t = (|μ-x|)/S;
where μ is the mean of the spot volumes in the normal
gels, x is the single observation in the LCA gel and S it the
standard deviation of μ. From the t-values obtained, we
calculated the two-tailed p-values. Spots that possessed p-
values below 0.05 were considered as significant and
selected for identification by MALDI-TOF mass spectrom-
etry.
Identification of proteins by mass spectrometry
Gels containing protein spots selected for identification
were re-swelled in water. The cellophane sheets were
peeled off so that the spots could be excised from the gels.
Proteins were subjected to trypsin digestion and subse-
quent identification by MALDI-TOF mass fingerprinting
(MS), performed as a service by Alphalyse A/S (Odense,
Denmark). The MS data was submitted to the ProFound –
Peptide Mapping facility [29].
Western blotting
The protein concentrations were measured with a Non-
Interfering Protein Assay (Geno Technology, Inc., St.
Louis, MO, USA). Ten μg of each samples were loaded and
run on 4–20% gradient polyacrylamide gels. After transfer
by electroelution to nitrocellulose Hybond C-extra mem-
branes, blots were blocked with 5% milk, 5% fetal calf
serum, and 0.05% Tween-20 in 80 mM Na2HPO4, 20 mM
NaH2PO4, 100 mM NaCl, pH 7.5 (PBS-T), and incubated
overnight at 4°C with anti-triosephosphate isomerase
(Everest Biotech, Oxfordshire, UK) diluted 1:1,000, anti-
αA-crystallin (Acris Antibodies, Hiddenhausen, Ger-
many) diluted 1:1,000, anti-β-tubulin (Abcam, Cam-
bridge, UK) diluted 1:1,000, and anti-ATP synthase
subunit β (Abcam, Cambridge, UK) diluted 1:500, anti-β-
actin (Abcam, Cambridge, UK) diluted 1:100. The labe-
ling was visualised with horseradish peroxidase-conju-
gated secondary antibodies (P217, P260 or P449, DAKO,
Glostrup Denmark, diluted 1:1,000 to 1:5,000) by using
the enhanced chemiluminescence system (Amersham
International).
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